Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma-Reference-Cited by-同舟云学术

Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma

Published:2012-06-26 Issue:5 Volume:33 Page:1785-1802
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Boonjaraspinyo Sirintip,Boonmars Thidarut,Wu Zhiliang,Loilome Watcharin,Sithithaworn Paiboon,Nagano Isao,Pinlaor Somchai,Yongvanit Puangrat,Nielsen Phuangphaka Sadee,Pairojkul Chawalit,Khuntikeo Narong

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-012-0438-8.pdf

Reference64 articles.

1. Kartha RV, Sundram UN. Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase-based tumorigenesis. Mod Pathol. 2008;21:96–104.

2. Heldin CH, Westermark B. Platelet-derived growth factor: three isoforms and two receptor types. Trends Genet. 1989;5:108–11.

3. Langley RR, Fidler IJ. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev. 2007;28:297–321.

4. Ostman A. PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev. 2004;15:275–86.

5. Pietras K, Sjoblom T, Rubin K, Heldin CH, Ostman A. PDGF receptors as cancer drug targets. Cancer Cell. 2003;3:439–43.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological and prognostic significance of VEGF, PDGF-B, and HER2/neu expression in gallbladder cancer;Journal of Cancer Research and Therapeutics;2024

2. CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS;Pharmaceuticals;2023-12-20

3. Targeting Angiogenesis in the Era of Biliary Tract Cancer Immunotherapy: Biological Rationale, Clinical Implications, and Future Research Avenues;Cancers;2023-04-19

4. Synonymous Variants: Necessary Nuance in Our Understanding of Cancer Drivers and Treatment Outcomes;JNCI: Journal of the National Cancer Institute;2022-04-27

5. Recent Advances in the Mechanism Research and Clinical Treatment of Anti-Angiogenesis in Biliary Tract Cancer;Frontiers in Oncology;2021-10-28